California Institute for Regenerative Medicine: Fool Me Once…

By Chris Centeno, MD /

Receive a Regenexx® Patient Info Packet by email and learn why it's a superior regenerative solution.

Way back in 2004, a plurality of California voters approved a multi-billion dollar bond issue to support embryonic stem cell research. Now the cupboards are bare and the reasons why CIRM didn’t work are emblematic of what’s wrong with letting bench scientists control regenerative medicine adoption. Let me explain.

The California Institute for Regenerative Medicine (CIRM)

The idea for CIRM began at a time during the Bush administration when evangelicals were in the political driver’s seat. Scientists had begun to understand that embryonic stem cells (ESCs) could repair tissue. However, many ESCs were sourced from aborted fetuses, which didn’t work for Bush, hence he put through a ban on federally funded embryonic stem cell research. What happened next shaped what we’re still dealing with in regenerative medicine almost two decades later.

Faced with literally being out of a job, ESC researchers organized. They formed the ISSCR or the International Society for Stem Cell Research in 2002. This helped with putting together California proposition 71 which also got support from many wealthy individuals and actors.

Frankly, looking back, this is where CIRM’s problems first began. In order to sell the idea of spending 3 billion dollars on research usually funded by the feds, ESC research was way oversold to the public. At some point, the then known scientific reality of ESCs became obvious science fiction. This messaging then got picked up by countless news organizations who then poured gasoline on the hype bonfire.

The bond issue was passed in 2004 by 59% of the voters and the CIRM was born. However, how the CIRM was sold, as a center for producing practical cures quickly, was not what was delivered. That stark disconnect was caused by inherent conflicts of interest in lettering bench scientists control medical breakthroughs.

CIRM-A Great Idea with Conflicts of Interest Galore

At face value, the idea of a state sponsoring research that the federal government doesn’t have the stomach for is not a bad idea. However, things were set up badly from the beginning. The governing board of the organization (who had the final say on grants awarded) had scientists representing the same universities who were the recipients of the grants. That, of course, should never have happened. That’s a bit like the NIH awarding research grants among a closed cabal of professors, most of whom are from the universities getting the grants.

In addition, the scientists had zero skin in the game when it came to actually producing cures. Meaning, their grants were not tied to actual progress towards a commercial or real-world application of the technology. There were also perverse incentives. Meaning, the need for more bench research meant more grants, hence why would anyone complete the basic science research phase and move the technology into the clinic? This was truly the fox guarding the proverbial 3 billion dollar hen house.

There are several examples of how bad this all got. For example, CIRM has spent hundreds of millions of dollars erecting new buildings on university campuses. Why? These universities already had plenty of buildings in which to perform their research. How would new buildings ever get CIRM closer to a real cure?

In fact, in 2013 the Institute of Medicine put out a scathing report on the governance of CIRM. The group cited institutionalized conflicts of interest which raised questions about the “the integrity and independence of some of CIRM’s decisions.” That report was supposed to bring in reform. However, just three years later, the California Stem Cell Report wrote that the former president of CIRM received more than 400K in compensation for a board seat just seven days after leaving his post. The company who paid him had received tens of millions in CIRM funding while he was in charge.

Another example is really the simplest. Here we are 15 years later and not a single commercially viable product has gained FDA approval for the clinic based on California’s 3 billion dollar bet. In addition, CIRM has spent most of the money, so it’s no longer awarding grants. Finally, the uber-wealthy who could write a check know a bad investment when they see one, which is how they got wealthy, so they are not stepping up to write more checks. Hence, CIRM is broke.

Anybody Who Knew How the Basic Science Research Game Works Could Have Seen This Coming

On the one hand, basic science medical research has produced and will produce many earth-shattering and groundbreaking new medical therapies and cures. These new therapies can save lives. Hence, basic science medical research is a good thing.

Having said that, basic science medical research is a business industry with commercial interests. Meaning, this industry thrives when there are more research grant dollars and starves when those dollars dry up. Considering that universities take about 30-40% of these grant dollars off the top as a fee (called Facilities and Administrative (F&A)), it’s fair to say that CIRM was a huge income source for universities. Which public and private universities benefitted? See below for an infographic:

How do we know this really happened? Just look at the STAT expose on CIRM:

“The National Institutes of Health has supported three and a half times as many human trials of stem cell therapies, dollar for dollar, as the California agency…”

“CIRM has…given more than $300 million to 27 projects that include clinical trials — though much of that funding also supported preclinical work. Meanwhile, the agency has committed about $540 million to new labs and buildings.”

There’s also an interesting piece in the SF Chronicle on how CIRM never delivered on its promises. For example, Stanford spent only 12% of the 360 million it received on four early-stage clinical trials, while 88% was spent on basic science research and buildings! You see a trend here? Bench scientists in control of stem cell research grant money funnel the vast majority of that money not toward clinical trials which get to real cures, but towards more bench science.

What’s Next? Fool Me Once…

Well, now CIRM wants a do-over. They want 5.5 billion more (you know, with inflation and all, that’s really 3 billion in 2004 dollars)! Hmmm…

However, we could have a perfect round 2 storm coming our way. In a move that looks like déjà vu, the current administration just halted all federally funded fetal tissue research. This, of course, may now create another political polarization around science, which by itself could be enough to fool California voters into reauthorizing the CIRM.

The CIRM Legacy is Alive and Well

While bench science talking heads go after stem cell clinics in news stories, the stem cell hype that fuels these clinics was begun by the CIRM! Ironic, isn’t it? The very scientists who are now against the clinical translation of stem cells are the same ones that lit the hype bonfire with prop 71. The same crew who have funneled billions of dollars into pet basic science projects while real clinical cures remained elusive.

Having said all of that, as you know from reading this blog, the prop 71 stem cell hype has been further morphed by many out of control clinicians. So I don’t often disagree with the university talking heads that patients are being misled and abused. However, it’s sure is fun to have been around all of this long enough to see the subtle ironies.

Conclusions

I love stem cell research and the more the merrier! However, let’s let NIH dole out those dollars. Why? They’re frankly better at it. But what about the current administration getting rid of fetal tissue coming from abortions? The science of the last two decades has taught us that ESC research was a boondoggle. If you want a stem cell with embryonic-like qualities, they can now be created through the reprogramming of adult cells. If you need stem cells derived from fetal tissue, you can get them from planned c-sections. So while this recent action will play well in politics, it doesn’t impact much of any real stem cell science at this point.

The upshot? This will be interesting to watch. As a physician-scientist, I’ve never been dialed into the CIRM gravy train. Hence, I really don’t have a dog in this upcoming fight. However, I do hope California voters look at all the facts here, as CIRM was a bait and switch if I ever saw one. In addition, I hope everyone takes notice that letting bench scientists with no skin in the game drive medical discoveries is a bad idea.

Category: Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *

4 thoughts on “California Institute for Regenerative Medicine: Fool Me Once…

  1. JUNE HUCHINGSON

    AS USUAL, DR. CEENTENO, YOU SHED LIGHT ON WHAT IS HAPPENING IN STEM CELL MEDICINE AND RESEARCH.

    THIS INFORMATION ABOUT RESEARCH GRANTS IS VERY DISTURBING. HOW CAN WE HELP CHANGE THE WAY THINGS ARE?

    CERTAINLY, PEOPLE NEED TO STRENGTHEN THEIR MEMORIES.

    PERHAPS THIS IS THE RIGHT TIME FOR YOU TO WRITE A BOOK (STEM CELL RESEARCH FOR DUMMIES?)
    ABOUT THE PAST HISTORY OF STEM CELL RESEARCH …
    THE PRESENT “WILD WEST” STEM CELL THERAPIES AND … THE LEGITIMATE THERAPIES AND STATISTICS …
    AND THE FUTURE POTENTIAL FOR THE USE OF STEM CELLS FOR HEALING. JUNE HUCHINGSON

  2. Barbara

    CIRM was like a gold rush for researchers. It was their own wild, wild west of research which used promises they knew couldn’t be kept to lure voters. Talk about snake oil! They are now trying to sugar coat the whole boondoggle, but they have no one but themselves to blame if voters give them a big, fat no on future funding. I agree that the NIH is far better able to dole out funding.

  3. merlon cox

    I truly loved this article. It was very informative, and an attention grabber! I’m one of those hoping for the day when our Insurance at UPS will get on board, and realize how important Regenexx stem cell science could possibly aid in the longevity, and health, of their employees. Thank you for the insight.

    1. Regenexx Team

      Hi Merlon,
      Glad you enjoyed it! You may want to talk to UPS, as many companies are now covering Regenexx procedures. Please see: https://regenexx.com/blog/stem-cell-procedure-insurance-coverage/

Chris Centeno, MD

Regenexx Founder

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications.
View Profile

Get Blog Updates by Email

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Regenerative procedures are commonly used to treat musculoskelatal trauma, overuse injuries, and degenerative issues, including failed surgeries.
Select Your Problem Area
Shoulder

Shoulder

Many Shoulder and Rotator Cuff injuries are good candidates for regenerative treatments. Before considering shoulder arthroscopy or shoulder replacement, consider an evaluation of your condition with a regenerative treatment specialist.

  • Rotator Cuff Tears and Tendinitis
  • Shoulder Instability
  • SLAP Tear / Labral Tears
  • Shoulder Arthritis
  • Other Degenerative Conditions & Overuse Injuries
Learn More
Cervical Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Knee

Knees

Knees are the target of many common sports injuries. Sadly, they are also the target of a number of surgeries that research has frequently shown to be ineffective or minimally effective. Knee arthritis can also be a common cause for aging athletes to abandon the sports and activities they love. Regenerative procedures can be used to treat a wide range of knee injuries and conditions. They can even be used to reduce pain and delay knee replacement for more severe arthritis.

  • Knee Meniscus Tears
  • Knee ACL Tears
  • Knee Instability
  • Knee Osteoarthritis
  • Other Knee Ligaments / Tendons & Overuse Injuries
  • And more
Learn More
Lower Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Hand & Wrist

Hand & Wrist

Hand and wrist injuries and arthritis, carpal tunnel syndrome, and conditions relating to overuse of the thumb, are good candidates for regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Hand and Wrist Arthritis
  • Carpal Tunnel Syndrome
  • Trigger Finger
  • Thumb Arthritis (Basal Joint, CMC, Gamer’s Thumb, Texting Thumb)
  • Other conditions that cause pain
Learn More
Elbow

Elbow

Most injuries of the elbow’s tendons and ligaments, as well as arthritis, can be treated non-surgically with regenerative procedures.

  • Golfer’s elbow & Tennis elbow
  • Arthritis
  • Ulnar collateral ligament wear (common in baseball pitchers)
  • And more
Learn More
Hip

Hip

Hip injuries and degenerative conditions become more common with age. Do to the nature of the joint, it’s not quite as easy to injure as a knee, but it can take a beating and pain often develops over time. Whether a hip condition is acute or degenerative, regenerative procedures can help reduce pain and may help heal injured tissue, without the complications of invasive surgical hip procedures.

  • Labral Tear
  • Hip Arthritis
  • Hip Bursitis
  • Hip Sprain, Tendonitis or Inflammation
  • Hip Instability
Learn More
Foot & Ankle

Foot & Ankle

Foot and ankle injuries are common in athletes. These injuries can often benefit from non-surgical regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Ankle Arthritis
  • Plantar fasciitis
  • Ligament sprains or tears
  • Other conditions that cause pain
Learn More

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

FOLLOW US

Copyright © Regenexx 2019. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email